Salvianolic acid B attenuates post-cardiac arrest cerebral ischemia–reperfusion injury via activation of the Nrf2 signaling pathway

SalB protects against CI/R-induced neurological injury by reducing oxidative stress, inflammation, and apoptosis through Nrf2 activation, supporting its potential as a therapeutic agent for post-CA cerebral injury.